<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">101235745</journal-id>
<journal-id journal-id-type="pubmed-jr-id">32213</journal-id>
<journal-id journal-id-type="nlm-ta">Am J Med Genet C Semin Med Genet</journal-id>
<journal-id journal-id-type="iso-abbrev">Am J Med Genet C Semin Med Genet</journal-id>
<journal-title-group>
<journal-title>American journal of medical genetics. Part C, Seminars in medical genetics</journal-title>
</journal-title-group>
<issn pub-type="ppub">1552-4868</issn>
<issn pub-type="epub">1552-4876</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27792859</article-id>
<article-id pub-id-type="pmc">5154879</article-id>
<article-id pub-id-type="doi">10.1002/ajmg.c.31529</article-id>
<article-id pub-id-type="manuscript">NIHMS823657</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Emerging Cellular and Gene Therapies for Congenital Anemias</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Ludwig</surname>
<given-names>Leif S.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="author-notes" rid="FN1">¶</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Khajuria</surname>
<given-names>Rajiv K.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="author-notes" rid="FN1">¶</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sankaran</surname>
<given-names>Vijay G.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="corresp" rid="cor1">*</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Division of Hematology/Oncology, Boston Children’s Hospital and Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.</aff>
<aff id="A2"><label>2</label>Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.</aff>
<aff id="A3"><label>3</label>Berlin-Brandenburg School for Regenerative Therapies, Charité-Universitätsmedizin Berlin, Berlin 13353, Germany.</aff>
<author-notes>
<corresp id="cor1"><label>*</label>Correspondence should be addressed to V.G.S. (<email>sankaran@broadinstitute.org</email>)</corresp>
<fn fn-type="equal" id="FN1">
<label>¶</label>
<p id="P1">These authors contributed equally to this work.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>18</day>
<month>10</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>28</day>
<month>10</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="ppub">
<month>12</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>12</month>
<year>2017</year>
</pub-date>
<volume>172</volume>
<issue>4</issue>
<fpage>332</fpage>
<lpage>348</lpage>
<!--elocation-id from pubmed: 10.1002/ajmg.c.31529-->
<abstract>
<p id="P2">Congenital anemias comprise a group of blood disorders characterized by a reduction in the number of peripherally circulating erythrocytes. Various genetic etiologies have been identified that affect diverse aspects of erythroid physiology and broadly fall into two main categories: impaired production or increased destruction of mature erythrocytes. Current therapies are largely focused on symptomatic treatment and are often based on transfusion of donor-derived erythrocytes and management of complications. Hematopoietic stem cell transplantation represents the only curative option currently available for the majority of congenital anemias. Recent advances in gene therapy and genome editing hold promise for the development of additional curative strategies for these blood disorders. The relative ease of access to the hematopoietic stem cell compartment, as well as the possibility of genetic manipulation <italic>ex vivo</italic> and subsequent transplantation in an autologous manner, make blood disorders among the most amenable to cellular therapies. Here we review cell-based and gene therapy approaches, and discuss the limitations and prospects of emerging avenues, including genome editing tools and the use of pluripotent stem cells, for the treatment of congenital forms of anemia.</p>
</abstract>
<kwd-group>
<kwd>anemia</kwd>
<kwd>red blood cells</kwd>
<kwd>cellular therapy</kwd>
<kwd>gene therapy</kwd>
<kwd>genome editing</kwd>
<kwd>hematopoiesis</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>